Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861560 · ClinicalTrials.gov registry record · NA
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02861560 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 10 participants.
The verdict
NCT02861560, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
A prospective case series investigating the efficacy and safety of dehydrated human amnion/chorion membrane (dHACM) in the treatment of patients with Stage II or III pressure ulcers
Interventions
- OTHER dHACM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02861560
The ClinicalTrials.gov registry entry for NCT02861560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dHACM is the first listed.
NCT02861560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02861560 about?
NCT02861560 is a clinical study titled "Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers". A prospective case series investigating the efficacy and safety of dehydrated human amnion/chorion membrane (dHACM) in the treatment of patients with Stage II or III pressure ulcers
What is the current status of trial NCT02861560?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-05. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02861560?
The interventions under investigation include: dHACM (OTHER).
Who is sponsoring clinical trial NCT02861560?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.